Metabotropic Glutamate2 Receptors Play a Key Role in Modulating Head Twitches Induced by a Serotonergic Hallucinogen in Mice
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabotropic Glutamate2 Receptors Play a Key Role in Modulating Head Twitches Induced by a Serotonergic Hallucinogen in Mice
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-03-15
DOI
10.3389/fphar.2018.00208
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 5-HT2A and mGlu2/3 receptor interactions
- (2016) Lena Wischhof et al. BEHAVIOURAL PHARMACOLOGY
- Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution
- (2016) Enzo Tagliazucchi et al. CURRENT BIOLOGY
- The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia
- (2016) Guy Griebel et al. Scientific Reports
- Tolerance to LSD and DOB induced shaking behaviour: Differential adaptations of frontocortical 5-HT2A and glutamate receptor binding sites
- (2015) Tobias Buchborn et al. BEHAVIOURAL BRAIN RESEARCH
- Exploratory Analysis for a Targeted Patient Population Responsive to the Metabotropic Glutamate 2/3 Receptor Agonist Pomaglumetad Methionil in Schizophrenia
- (2015) Bruce J. Kinon et al. BIOLOGICAL PSYCHIATRY
- The reversal of cognitive, but not negative or positive symptoms of schizophrenia, by the mGlu2/3 receptor agonist, LY379268, is 5-HT1A dependent
- (2013) Joanna M. Wierońska et al. BEHAVIOURAL BRAIN RESEARCH
- The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4receptors in rodents
- (2013) Anna Sławińska et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
- (2013) Jeffrey Cummings et al. LANCET
- Chronic treatment with LY341495 decreases 5-HT2A receptor binding and hallucinogenic effects of LSD in mice
- (2013) José L. Moreno et al. NEUROSCIENCE LETTERS
- Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model
- (2012) Clint E. Canal et al. Drug Testing and Analysis
- Identification of Three Residues Essential for 5-Hydroxytryptamine 2A-Metabotropic Glutamate 2 (5-HT2A·mGlu2) Receptor Heteromerization and Its Psychoactive Behavioral Function
- (2012) José L. Moreno et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CNS distribution of metabotropic glutamate 2 and 3 receptors: Transgenic mice and [3H]LY459477 autoradiography
- (2012) Rebecca A. Wright et al. NEUROPHARMACOLOGY
- Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis
- (2012) Robin L. Carhart-Harris et al. SCHIZOPHRENIA BULLETIN
- Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists
- (2011) José L. Moreno et al. NEUROSCIENCE LETTERS
- Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT)
- (2010) Meredith A Fox et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of a Positive Allosteric Modulator of Group II Metabotropic Glutamate Receptors, LY487379, on Cognitive Flexibility and Impulsive-Like Responding in Rats
- (2010) A. Nikiforuk et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a Novel Metabotropic Glutamate 2 Potentiator with Potential Anxiolytic/Antidepressant Properties: In Vivo Profiling Suggests a Link between Behavioral and Central Nervous System Neurochemical Changes
- (2010) M. J. Fell et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The Presynaptic Component of the Serotonergic System is Required for Clozapine's Efficacy
- (2010) Prem N Yadav et al. NEUROPSYCHOPHARMACOLOGY
- PSD-95 Is Essential for Hallucinogen and Atypical Antipsychotic Drug Actions at Serotonin Receptors
- (2009) A. I. Abbas et al. JOURNAL OF NEUROSCIENCE
- Activation of adenosine1 (A1) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats
- (2009) Gerard J. Marek NEUROPHARMACOLOGY
- Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis
- (2009) Herbert Y Meltzer et al. NEUROPSYCHOPHARMACOLOGY
- The Hallucinogen DOI Reduces Low-Frequency Oscillations in Rat Prefrontal Cortex: Reversal by Antipsychotic Drugs
- (2008) Pau Celada et al. BIOLOGICAL PSYCHIATRY
- Identification of a serotonin/glutamate receptor complex implicated in psychosis
- (2008) Javier González-Maeso et al. NATURE
- Sustained treatment with a 5-HT2A receptor agonist causes functional desensitization and reductions in agonist-labeled 5-HT2A receptors despite increases in receptor protein levels in rats
- (2008) Ju Shi et al. NEUROPHARMACOLOGY
- AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakes
- (2007) Ce Zhang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started